Publications Database

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. et al. (2017)

Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

March, 27(2), pp. 125-131.

Read Abstract (New Window) Read Full (New Window)

Shea S. et al. (2004)

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Pediatrics

114(5), e. 634-641

Read Abstract (New Window) Read Full (New Window)

Sheppard K. et al.

Effect of omega-3 and -6 supplementation on language in preterm toddlers exhibiting autism spectrum disorder symptoms.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Simonoff E. et al. (2013)

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Journal of Child Psychology and Psychiatry

54(5), pp. 527-535.

Read Abstract (New Window)

Singh K. et al. (2014)

Sulforaphane treatment of autism spectrum disorder (ASD).

Proceedings of the National Academy of Science U S A

111(43), pp. 15550-15555.

Read Abstract (New Window) Read Full (New Window)

Spencer E. K. , Alpert M. , Pouget E. (1994)

Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS.

Psychosomatic Medicine

30(2), pp. 199-202

Read Abstract (New Window)

Sponheim E. , Oftedal G. , Helverschou S. B. (2002)

Multiple doses of secretin in the treatment of autism: a controlled study.

Acta Paediatrica

91(5), pp. 540-545.

Read Abstract (New Window)

Steenburgh J. J. v. et al. (2017)

Balanced bifrontal transcranial direct current stimulation enhances working memory in adults with high-functioning autism: A sham-controlled crossover study.

Molecular Autism

8(40),

Read Abstract (New Window) Read Full (New Window)

Strayhorn J. M. et al. (1998)

Randomized trial of methylphenidate for an autistic child.

Journal of the American Academy of Child and Adolescent Psychiatry

27(2), pp. 244-247

Read Abstract (New Window)

Sugie Y. et al. (2005)

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Journal of Autism and Developmental Disorders

35(3), pp. 377-385

Read Abstract (New Window)

Tolbert L. et al. (1993)

Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.

Journal of Autism and Developmental Disorders

23(1), pp. 193-199

Read Abstract (New Window)

Troost P. et al. (2005)

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Journal of the American Academy of Child and Adolescent Psychiatry

44(11), pp. 1137-1144

Read Abstract (New Window)

Tyrer P. et al. (2008)

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.

Lancet

371(9606), pp. 57-63.

Read Abstract (New Window)

Umbricht D. et al. (2016)

A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.

Neuropsychopharmacology

Read Abstract (New Window)

Unis A. et al. (2002)

A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.

Journal of the American Academy of Child and Adolescent Psychiatry

41(11),

Read Abstract (New Window)

Varni J. W. et al. (2012)

Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: A post hoc analysis of two controlled trials.

Clinical Therapeutics

34(4), pp. 980-992.

Read Abstract (New Window)

Veenstra-VanderWeele J. et al.

Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial.

Neuropsychopharmacology

Read Abstract (New Window)

Vitiello B. et al. (2005)

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.

Journal of Clinical Psychopharmacology

25(6), pp. 565-569

Read Abstract (New Window)

Voigt R. G. et al. (2014)

A randomized, double-blind, placebo-controlled trial of dietary docosahexaenoic acid (DHA) supplementation in children with autism.

Journal of Pediatric Gastroenterology and Nutrition

June, 58(6), pp. 715-722.

Read Abstract (New Window)